PDE5A and pulmonary arterial hypertension: Sildenafil, which is a selective PDE-5 inhibitor, is a vasodilator that can be administered orally and is approved for use in adults with PAH and commonly used off-label in children due to the potential morbidity and mortality associated with untreated PH.